NSEGeneral Updates6 Oct 2026 · 6 Oct 2026, 11:19 am
General Updates
Privi Speciality Chemicals Limited · PRIVISCL
✦ AI SummaryM&A
Privi Speciality Chemicals Limited has informed the Exchange about Notice of Meeting of Equity Shareholders in the matter of Scheme of Amalgamation scheduled to be held on October 27, 2026, to consider the amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with Privi Speciality Chemicals Limited.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Privi Speciality Chemicals Limited has informed the Exchange about Notice of Meeting of Equity Shareholders (Meeting) of the Company in the matter of Scheme of Amalgamation scheduled to be held on on Tuesday, October 27, 2026, at 12.30 p.m.
Attachments (1)
📄pdf
Download →
FAIRCHEMDP_06102026111909_NoticetoNSE.pdf
View document text
BEFORE THE NATIONAL COMPANY LAW TRIBUNAL,
MUMBAI BENCH
FORM NO. CAA-3
[Pursuant to Section 230(5) and Rule 8]
CA(CAA)/136/MB-rV/2026
In the matter of the Companies Act, 2013;
In the matter of Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 and
Rules framed thereunder as in force from time to time;
In the matter of Scheme of Amalgamation ofPRIVI FINE SCIENCES PRIVATE LIMITED, the
Transferor Company 1 and PRIVI BIOTECHNOLOGIES PRIVATE LIMITED, the Transferor
Company 2 with PRIVI SPECIALITY CHEMICALS LIMITED, the Transferee Company.
Privi Speciality Chemicals Limited (AAACH5113Q) ..Applicant Company
Date: 06/10/2026
National Stock Exchange of India Ltd.
Exchange Plaza, Plot no. C/l, G Block,
Bandra-Kurla Complex, Bandra (East)
Mumbai-400051
Notice is hereby given in pursuance of sub-section (5) of section 230 of the Companies Act, 2013, that
as directed by the Hon'ble Mumbai Bench of National Company Law Tribunal, Mumbai ("Tribunal")
at 4th, 5th & 6th Floor, MTNL Exchange Building, Next to G.D. Somani School, Cuffe Parade,
Mumbai- 400005 by an order dated 7th September, 2026 has dispensed the requirement of holding the
meetings of (a) the members, secured and unsecured creditors of Privi Fine Sciences Private Limited,
the Transferor Company 1; (b) the members and unsecured creditors ofPrivi Biotechnologies Private
Limited, the Transferor Company 2; (c) the secured and unsecured creditors of Privi Speciality
Chemicals Limited, the Transferee Company. Further, a meeting of the members of Privi Speciality
Chemicals Limited, the Transferee Company shall be held on 27th October, 2026 (through OAVM) to
consider the Scheme of Amalgamation ofPrivi Fine Sciences Private Limited, the Transferor Company
1 and Privi Biotechnologies Private Limited, the Transferor Company 2 with Privi Speciality Chemical^^CA^s
Limited, the Transferee Company. •^
0- OFFiCE .0
PRIVI SPECIALITY CHEMICALS LIMITED -\
"/ t,^
1809001:2015
18014001:2015
ISO 45001:2018 Knowledge Centre & Regd. Office : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station,
BUREAU VERITAS Navi Mumbai - 400 710. India | Tel.: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045
Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | GIN: L15140MH1985PLC286828
A Copy of the Order dated 7th September, 2026 along with a Scheme of Amalgamation is enclosed
herewith.
You are hereby informed that representations, if any, in connection with the proposed Scheme of
Amalgamation may be made to the Tribunal within thirty days from the date of receipt of this notice.
Copy of the representation may simultaneously be sent to the respective Company at their registered
office address.
In case no representation is received within the stated period of thirty days, it shall be presumed that
you have no representation to make on the proposed scheme of amalgamation.
For Privi Speciality Chemicals Limited,
5T £P
£ REGD. s
Ashwini Saumil Shah
c *- OFFICE ~u 1{
Company Secretary & Compliance officer f^ ^
:'/ffibai
End: Copy of order dt. 7th September, 2026
Copy of the Notice calling the Meeting of Equity Shareholders
Copy of the Scheme of Amalgamation
PRIVI SPECIALIT/ CHEMICALS LIMITED
1809001:2015
13014001:2015
18045001:2018 Knowledge Centre & Regd. OKice : Privi House, A-71, TTC, Thane Belapur Road, Near Kopar Khairane Railway Station,
BUREAU VERITAS Navi Mumbai - 400 710. India | Tel.: +91 22 68713200 / 33043500 / 33043600 / 27783040 / 27783041 / 27783045
Certification Fax: +91 2227783049/68713232 | Email: enquiry@privi.co.in | Web: www.privi.com | GIN: L15140MH1985PLC286828
IN THE NATIONAL COMPANY LAW TRIBUNAL, MUMBAI
COURT-IV
CA(CAA)-136/MB/2026
In the matter of
Sections 230 to 232 of the Companies Act, 2013
In the matter of
Scheme of Amalgamation
Privi Fine Sciences Private Limited
(Transferor Company-1/Applicant-1)
Privi Biotechnologies Private Limited
(Transferor Company-2/Applicant-2)
with
Privi Speciality Chemicals Limited
(Transferee Company/Applicant-3)
Privi Fine Sciences Private Limited ….Applicant Company-1/
[CIN: U24110MH2021PTC358857] Transferor Company-1
Privi Biotechnologies Private Limited ….Applicant Company-2/
[CIN: U74220MH1985PTC037534] Transferor Company-2
Privi Speciality Chemicals Limited ….Applicant Company-3/
[CIN: L15140MH1985PLC286828] Transferee Company
Pronounced: 07.09.2026
CORAM:
SHRI ANIL RAJ CHELLAN SHRI K.R. SAJI KUMAR
HON’BLE MEMBER (TECHNICAL) HON’BLE MEMBER (JUDICIAL)
Appearance : Hybrid
National Company Law Tribunal
For the Applicants : Mr. Ashish O. LalpurMiuam baa/i wBe nMchr. Kamal
LahoAptpylic,a tPionC NoS.: CCR/NCLT/2026/136/01264
Date of Application: 2026-09-08
No. of Pages: 15
Valid with Facing Sheet Only.:
IN THE NATIONAL COMPANY LAW TRIBUNAL, MUMBAI
COURT-IV
CA(CAA)/136/MB/2026
O R D E R
1. This is an Application filed under Sections 230 to 232 of the Companies Act, 2013,
seeking necessary directions of this Tribunal for notices and convening
meetings/dispensation of meetings of the shareholders and creditors of the
Applicant Companies with respect to the Scheme of Amalgamation of Privi Fine
Sciences Private Limited (Transferor Company-1) and Privi Biotechnologies
Private Limited (Transferor Company-2) with Privi Speciality Chemicals Limited
(Transferee Company).
2. The Applicant Companies stated that the Board of Directors of the Applicant
Companies, in their respective meetings held on 19.12.2025, have approved the
Scheme. All the relevant resolutions are part of the Application. The Appointed
Date fixed for the Scheme is 01.10.2025.
3. The Applicant Companies further stated that Applicant Company 1 and 2 are not
listed on any Stock Exchange. The Applicant Companies are not governed by
any sectoral regulators. Further, the Applicant Company 1 and 2 are not required
to issue notice upon the Securities and Exchange Board of India, Competition
Commission of India and Reserve Bank of India.
4. The Applicant Companies further stated that the shares of the Applicant
Company 3 are listed on National Stock Exchange (NSE) and Bombay Stock
Exchange (BSE) and are governed by the sectoral regulators. Pursuant to which,
the Applicant Company 3 has obtained a No Objection Letter from NSE bearing
reference no. NSE/LIST/52681 dated 05.05.2026 and a No Objection Letter from
BSE bearing reference no. DCS/AMAL/RD/R37/53/2026-27 dated 06.05.2026.
Company has furnished an undertaking which is in compliance with the No
Objection Letter. Further stated that the Applicant Company 3 is not required to
issue notice to the Securities and Exchange Board of India, the Competition
National Company Law Tribunal
Commission of India, and the Reserve Bank of India. Copy Moufm bleai tBteenrchs from BSE
Application No.: CCR/NCLT/2026/136/01264
and NSE are part of the Application.
Date of Application: 2026-09-08
No. of Pages: 15
Valid with Facing Sheet Only.:
5. Nature of Business: It is submitted by the Applicant Companies that –
Page 2 of 15
IN THE NATIONAL COMPANY LAW TRIBUNAL, MUMBAI
COURT-IV
CA(CAA)/136/MB/2026
(i) The Transferor Company-1 is engaged in the business of manufacturer,
exports, and trading in Specialty chemicals and other chemical products.
(ii) The Transferor Company-2 is engaged in the business of manufacturer,
trading, researchers, developers, creators of Specialty chemicals and other
chemical products.
(iii) The Transferee Company is engaged in the business of manufacture, trading
and export of bulk Aroma and Specialty chemicals.
6. Rationale of the Scheme: The Applicant Companies stated that the rationale for
the proposed scheme of amalgamation is as follows:
6.1 As the Transferor Companies 1 and 2 are engaged in a similar line of business
to the Transferee Company, the amalgamation will enhance and strengthen the
Transferee Company's business by improving its operational capabilities and
market competitiveness. It aims to enrich the combined product offerings and
expand the cu
[Showing first 8,000 characters — download PDF for full document]